Transfection reagent for rAAV production in suspension, FectoVIR®-AAV
Supplier: Polyplus-transfection
Next generation of transfection reagent for rAAV production in suspension.
- High performance: Superior yield for AAV production
- Scalability: Developed for small to large scale manufacturing
- Flexibility: Compatible with commercial culture media
- Trustworthy: #1 transfection supplier of gene and cell therapy
- GMP compliance: GMP grade coming soon
FectoVIR®-AAV is a novel class of animal free transfection reagent specifically developed for research development up to industrial scale production of recombinant AAV (rAAV) viral vectors in suspension HEK-293 cell types. FectoVIR®-AAV transfection reagent guarantees higher rAAV viral titers, improved flexibility and scalability for industrial scale manufacturing.
Since 1st of September 2021 Polyplus-Tranfection changed product part numbers. Products are remaining the same and the change is only related to the product part number. New product part numbers have symbol “New”. For duplicated products with symbol “telephone” please be informed that it’s the same product but with previous part number which we will only offer till the end of stock.
Certifications: Since 2002, Polyplus-transfection® is ISO 9001 certified and since then this certification has been successfully renewed every three years.
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...